Plancorp, LLC Bristol Myers Squibb CO Transaction History

Plancorp, LLC

$2.3 Billion
Q2 2024

A detailed history of Plancorp, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Plancorp, LLC holds 9,607 shares of BMY stock, worth $510,996. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,607

Previous 9,481 1.33%

Holding current value

$510,996

Previous $514,000 22.57%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$40.25 - $52.99 $5,071 - $6,676	126 Added 1.33%	9,607 $398,000
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $5,229 - $5,929	109 Added 1.16%	9,481 $514,000
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $3,732 - $4,454	-77 Reduced 0.81%	9,372 $480,000
Q3 2023 Nov 08, 2023	BUY	$57.89 - $64.73 $27,555 - $30,811	476 Added 5.3%	9,449 $548,000
Q2 2023 Jul 26, 2023	BUY	$63.71 - $70.74 $17,520 - $19,453	275 Added 3.16%	8,973 $573,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $2,496 - $2,832	38 Added 0.44%	8,698 $602,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $6,711 - $7,946	98 Added 1.14%	8,660 $623,000
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $42 - $25,357	-330 Reduced 3.71%	8,562 $609,000
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $32,533 - $35,831	448 Added 5.31%	8,892 $685,000
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $24,899 - $29,856	405 Added 5.04%	8,444 $617,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $21,130 - $24,632	-394 Reduced 4.67%	8,039 $501,000
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $31,064 - $36,387	525 Added 6.64%	8,433 $499,000
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $128,772 - $140,233	-2,080 Reduced 20.82%	7,908 $528,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $51,744 - $58,197	-872 Reduced 8.03%	9,988 $631,000
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $39,494 - $44,754	684 Added 6.72%	10,860 $674,000
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $5,398 - $5,982	94 Added 0.93%	10,176 $614,000
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $35,194 - $41,145	-642 Reduced 5.99%	10,082 $593,000
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $26,772 - $38,907	577 Added 5.69%	10,724 $598,000
Q4 2019 Feb 03, 2020	BUY	$49.21 - $64.19 $213,866 - $278,969	4,346 Added 74.92%	10,147 $651,000
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $1,283 - $1,521	-30 Reduced 0.51%	5,801 $294,000
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $30,341 - $33,551	-680 Reduced 10.44%	5,831 $264,000
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $45,029 - $53,692	998 Added 18.1%	6,511 $311,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $69,483 - $90,102	-1,425 Reduced 20.54%	5,513 $287,000
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $24,228 - $27,327	439 Added 6.75%	6,938 $431,000
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $151 - $188	3 Added 0.05%	6,499 $360,000
Q1 2018 Apr 16, 2018	BUY	$59.92 - $68.98 $42,722 - $49,182	713 Added 12.33%	6,496 $412,000
Q4 2017 Jan 19, 2018	BUY	$59.94 - $65.35 $17,922 - $19,539	299 Added 5.45%	5,783 $353,000
Q3 2017 Oct 11, 2017	BUY	$55.23 - $63.74 $302,881 - $349,550	5,484	5,484 $351,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Plancorp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plancorp, LLC with notifications on news.

Account